ALPHA-(4-TOLYLIMINO)-P-CRESOL 96
- $45 - $674.77
- Product name: ALPHA-(4-TOLYLIMINO)-P-CRESOL 96
- CAS: 3230-51-1
- MF: C14H13NO
- MW: 211.26
- EINECS:
- MDL Number:MFCD00029735
- Synonyms:ALPHA-(4-TOLYLIMINO)-P-CRESOL 96;N-(4-Hydroxybenzylidene)-p-toluidine;α-(4-Tolylimino)-p-cresol;Phenol, 4-[[(4-methylphenyl)imino]methyl]-;4-{(E)-[(4-methylphenyl)imino]methyl}phenol;4-((P-tolylimino)methyl)phenol
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Sigma-Aldrich
- TRC
Package
- 10mg
- 250mg
- 500mg
- 1G
- ManufacturerAK Scientific
- Product number8554BA
- Product description4-{(E)-[(4-Methylphenyl)imino]methyl}phenol
- Packaging500mg
- Price$264
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0117308
- Product descriptionALPHA-(4-TOLYLIMINO)-P-CRESOL 95.00%
- Packaging1G
- Price$674.77
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS684805
- Product descriptionALPHA-(4-TOLYLIMINO)-P-CRESOL Aldrich
- Packaging250mg
- Price$110
- Updated2024-03-01
- Buy
- ManufacturerTRC
- Product numberE521658
- Product description4-{(E)-[(4-methylphenyl)imino]methyl}phenol
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8554BA | 4-{(E)-[(4-Methylphenyl)imino]methyl}phenol | 500mg | $264 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0117308 | ALPHA-(4-TOLYLIMINO)-P-CRESOL 95.00% | 1G | $674.77 | 2021-12-16 | Buy |
Sigma-Aldrich | S684805 | ALPHA-(4-TOLYLIMINO)-P-CRESOL Aldrich | 250mg | $110 | 2024-03-01 | Buy |
TRC | E521658 | 4-{(E)-[(4-methylphenyl)imino]methyl}phenol | 10mg | $45 | 2021-12-16 | Buy |
Properties
Melting point :218-222 °C(lit.)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|